Trial Profile
A Phase II, Randomized, Single-Dose, Unblinded Study to Compare the Efficacy and Safety of the CollaRx Bupivacaine Implant With the ON-Q PainBuster Post-op Pain Relief System in Women Following Abdominal Hysterectomy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Innocoll
- 06 Feb 2013 Data from this trial has been published in the Journal of Pain Research, according to an Innocoll media release.
- 25 Mar 2009 Actual numbe of patients (27) added as reported by CLinicalTrials.gov
- 25 Mar 2009 Actual end date (1 Dec 2008) added as reported by ClinicalTrials.gov.